Comparisons
Mod GRF 1-29 vs CJC-1295: What the Names Mean
Mod GRF 1-29 and CJC-1295 without DAC usually name the same molecule. The DAC version is a different compound. How to tell from the report.
Tag: CJC-1295
Comparisons
CJC-1295 With GHRP-2 or GHRP-6: Why They Are Paired
A GHRH analogue and a GHRP act at two different receptors, which is the stated rationale for pairing them. What the literature does and does not show.
Peptide Profiles
GH Peptide Blends: Sermorelin, Tesamorelin and Ipamorelin
What sermorelin/ipamorelin and tesamorelin/CJC-1295/ipamorelin blends contain, how to calculate each component, molar ratios and how blends are tested.
Comparisons
Sermorelin vs Ipamorelin vs Tesamorelin: Three Routes to GH
Sermorelin, tesamorelin and CJC-1295 act on the GHRH receptor; ipamorelin and MK-677 on the ghrelin receptor. How the two classes differ and compare.
Comparisons
Tesamorelin vs CJC-1295: Two Ways to Stabilise GHRH
Tesamorelin keeps all 44 GHRH residues with an N-terminal cap; CJC-1295 shortens to 1-29 and substitutes four residues. How the two strategies compare.
Lab Handling
CJC-1295 Storage: Why the DAC Version Differs
CJC-1295 with DAC carries a reactive maleimide group; the no-DAC version does not. That difference changes how each should be stored and handled.
Comparisons
Sermorelin vs CJC-1295: What Actually Differs
Sermorelin and CJC-1295 act at the same receptor. The difference is degradation resistance and circulating duration, not mechanism. A side-by-side comparison.
Peptide Profiles
CJC-1295 + Ipamorelin: Two GH Pathways in One Vial
CJC-1295 (no DAC) acts on the GHRH receptor and ipamorelin on the ghrelin receptor. Why they are paired, what each has been shown to do, and blend lab handling.
Peptide Profiles
What Is CJC-1295? GHRH Analogue With and Without DAC
CJC-1295 is a modified GHRH(1-29) analogue; the DAC version binds albumin for a 6–8 day half-life. Structure, human GH/IGF-I data, detection and handling.
Comparisons
CJC-1295 With DAC vs Without DAC: What DAC Means
DAC (drug affinity complex) lets CJC-1295 bind albumin, turning a short-acting GHRH analogue into one with a ~1-week half-life. How the two forms differ.